======= NLRP4 ======= == Gene Information == * **Official Symbol**: NLRP4 * **Official Name**: NLR family pyrin domain containing 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=147945|147945]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96MN2|Q96MN2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NLRP4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NLRP4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609645|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a member of the nucleotide-binding and leucine-rich repeat receptor (NLR) family, and is predicted to contain an N-terminal pyrin effector domain (PYD), a centrally-located nucleotide-binding and oligomerization domain (NACHT) and C-terminal leucine-rich repeats (LRR). This gene product has a demonstrated role as a negative regulator of autophagy and type I interferon signaling pathways as a result of protein interactions with its NACHT domain. The PYD domain has also been shown to be important in the inhibition of NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells). [provided by RefSeq, Dec 2016]. * **UniProt Summary**: May be involved in inflammation and recognition of cytosolic pathogen-associated molecular patterns (PAMPs) not intercepted by membrane-bound receptors. Acts as a negative regulator of the type I interferon signaling pathway by serving as an adapter to promote DTX4-mediated ubiquitination of activated TBK1, and its subsequent degradation. Suppresses NF-kappaB induction by the cytokines TNFA and IL1B, suggesting that it operates at a point of convergence in these two cytokine signaling pathways. {ECO:0000269|PubMed:12093792, ECO:0000269|PubMed:22388039}. |NACHT| |PAAD DAPIN| |regulation of type I interferon production| |inflammatory response| |regulation of cytokine production| |defense response| |ATP binding| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp300|VE-822 0.04μM R06 exp300]]|-2.27| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.75| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|-1.73| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|-1.73| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-1.7| |[[:results:exp292|Menadione 5μM R06 exp292]]|1.78| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.83| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11064 * **Expression level (log2 read counts)**: -5.01 {{:chemogenomics:nalm6 dist.png?nolink |}}